New Delhi, Oct. 23 -- Hyderabad-based drugmaker Dr Reddy's Laboratories Ltd on Thursday said it has isolated all its data centre servers across the world for as long as a day, as a preventive action a... Read More
NEW DELHI, Oct. 23 -- Bharat Biotech International Ltd plans to launch its covid-19 vaccine--Covaxin--by June next year, unless the government decides to give the vaccine an emergency use authorisatio... Read More
NEW DELHI, Oct. 23 -- Bharat Biotech International Ltd plans to launch its covid-19 vaccine--Covaxin--by June next year, unless the government decides to give the vaccine an emergency use authorisatio... Read More
NEW DELHI, Oct. 22 -- Serum Institute of India has entered into an agreement with German pharmaceutical giant Merck KGaA and IAVI, a non-profit health research organization, to develop two monoclonal ... Read More
New Delhi, Oct. 22 -- The government expects a covid-19 vaccine to be ready for sale as early as December if clinical trials are successful, a senior health ministry official said. "It is difficult t... Read More
NEW DELHI, Oct. 22 -- Hyderabad-based drugmaker Dr Reddy's Laboratories has isolated all its data centre servers across the world for up to a day as a preventive action after detecting a cyberattack. ... Read More
NEW DELHI, Oct. 22 -- Hyderabad-based drugmaker Dr Reddy's Laboratories has isolated all its data centre servers across the world for up to a day as a preventive action after detecting a cyberattack. ... Read More
New Delhi, Oct. 20 -- The government is planning to delete convalescent plasma therapy from the national guidelines for covid-19 treatment after the Indian Council of Medical Research's clinical trial... Read More
NEW DELHI, Oct. 18 -- Russian Direct Investment Fund (RDIF) has signed a pact with Delhi-based pharmaceutical company Mankind Pharma for marketing and distribution of its Sputnik V vaccine, two source... Read More
New Delhi, Oct. 17 -- A World Health Organization (WHO) trial of Gilead Sciences Inc.'s remdesivir, the antiviral drug used to treat US President Donald Trump, showed little or no effect on the surviv... Read More